Warberg Asset Management LLC - LIXTE BIOTECHNOLOGY HLDGS IN ownership

LIXTE BIOTECHNOLOGY HLDGS IN's ticker is LIXTW and the CUSIP is 539319111. A total of 5 filers reported holding LIXTE BIOTECHNOLOGY HLDGS IN in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Warberg Asset Management LLC ownership history of LIXTE BIOTECHNOLOGY HLDGS IN
ValueSharesWeighting
Q3 2023$2,575
-30.5%
40,875
-23.1%
0.00%0.0%
Q2 2023$3,707
-19.0%
53,1810.0%0.00%0.0%
Q1 2023$4,579
+129.0%
53,181
+343.2%
0.00%
Q2 2022$2,000
-87.5%
12,000
-81.9%
0.00%
Q1 2022$16,000
+100.0%
66,406
+270.3%
0.00%
-100.0%
Q4 2021$8,000
-60.0%
17,934
-50.2%
0.00%
-66.7%
Q3 2021$20,000
+81.8%
35,996
+150.8%
0.00%
+50.0%
Q2 2021$11,000
-50.0%
14,354
-46.0%
0.00%
-71.4%
Q1 2021$22,000
+83.3%
26,600
+104.6%
0.01%
+133.3%
Q4 2020$12,00013,0010.00%
Other shareholders
LIXTE BIOTECHNOLOGY HLDGS IN shareholders Q1 2023
NameSharesValueWeighting ↓
Empery Asset Management, LP 99,835$12,0000.06%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 32,284$4,0000.00%
CLEAR STREET LLC 85,211$10,0000.00%
Warberg Asset Management LLC 12,000$2,0000.00%
UBS Group AG 7,533$1,0000.00%
View complete list of LIXTE BIOTECHNOLOGY HLDGS IN shareholders